Test method for researching uric acid-induced meniscus lesion mechanism

Through the experimental method of studying the mechanism of uric acid inducing meniscus lesions, the negative impact of uric acid on meniscus function was clarified, providing important information for the early prevention and clinical treatment of meniscus damage, and solving the existing technology of high uric acid and meniscus The problem of lack of research on the impairment relationship.

CN119001077APending Publication Date: 2024-11-22CHONGQING MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411239638.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The lack of in-depth research on the relationship and mechanism between high uric acid and meniscus damage in the prior art has led to a lack of new ideas for clinical treatment and repair.

Method used

A test method to study the mechanism of meniscus lesions inducing uric acid, by collecting patient blood test information, isolating and extracting MeSCs, detecting the effect of uric acid on MeSCs, establishing a rat hyperuric acid model, studying the effect of uric acid on meniscus tissue, and verifying uric acid The cellular function and meniscus structure of MeSCs are affected through multiple molecular mechanisms.

Benefits of technology

The negative impact of uric acid on meniscus functional stability and injury repair is clarified, and serum high uric acid may be a potential cause of meniscus degenerative changes, providing important information for early prevention and clinical treatment of meniscus injury.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119001077A_ABST
    Figure CN119001077A_ABST
Patent Text Reader

Abstract

The invention discloses a test method for researching a uric acid-induced meniscus lesion mechanism, and relates to the technical field of meniscus lesion mechanisms. Comprising the following steps: S1, collecting fasting venous blood detection information of 1051 meniscus injury patients and 2027 healthy physical examinees, and comparing serum kidney function indexes of the meniscus injury patients and the healthy physical examinees; multiple times of detection prove that uric acid can influence the cell dryness of MeSCs from multiple biological function levels through multiple complex molecular mechanisms, the number of stem cells playing an important role in meniscus function stability maintenance and damage repair is reduced, degenerative lesion of meniscus tissue is promoted, finally, tissue damage to the meniscus is more likely to happen, and the meniscus tissue repair effect is improved. Uric acid is closely related to meniscus, and high serum uric acid content may be one of potential inducements causing meniscus degenerative change, so that valuable clues and important information are provided for early prevention and clinical treatment of meniscus injury.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of meniscus pathological mechanism, and in particular to an experimental method for studying the mechanism of meniscus pathological changes induced by uric acid. Background Art

[0002] Uric acid (UA) is the final product of purine nucleotide metabolism. Human uric acid has two sources. One part comes from cellular metabolism such as amino acids and nucleic acids, which is called endogenous uric acid; the uric acid produced by the catabolism of ingested food is called exogenous uric acid. Because humans lack uricase, the level of human serum uric acid (SUA) is higher than that of other mammals containing uricase. When excessive intake of high-purine foods will cause the balance of UA production and excretion to be broken, and the SUA level will increase, which will cause the occurrence of hyperuricemia. Studies have found that urate deposits exist on the meniscus of gout patients, which has an adverse effect on the structure and function of the meniscus.

[0003] The meniscus is an internal structure of the knee joint and is vital to a healthy knee joint. If the meniscus is damaged due to injury or degenerative processes, the risk of diseases such as arthritis will increase dramatically. The meniscus has few blood vessels and poor blood supply. There is a certain degree of protective autophagy in the meniscus tissue cells, so meniscus injuries are often difficult to heal. Meniscus mesenchymal stem cells are stem cells with self-renewal capabilities found in the meniscus. The cell population of meniscus mesenchymal stem cells is smaller, grows slower, and is more inclined to differentiate into chondrocytes. When the meniscus is damaged, MeSCs can migrate to the site of injury through chemotaxis and exert the repair function of the meniscus tissue. Therefore, MeSCs play an important role in the repair of meniscus tissue damage and the maintenance of stability;

[0004] However, most of the current research on meniscus focuses on external factors of injury and improvements in clinical treatment. There is a lack of research on the relationship and mechanism between hyperuricemia and meniscus injury. Therefore, it is necessary to use hyperuricemia as an influencing factor to explore its effect on MeSCs and its role in the meniscus injury process from the molecular mechanism level, so as to provide new ideas for the clinical treatment and repair of meniscus injury. Summary of the invention

[0005] The purpose of the present invention is to solve the shortcomings of the prior art and to propose an experimental method for studying the mechanism of uric acid-induced meniscus lesions.

[0006] In order to achieve the above object, the present invention adopts the following technical solutions:

[0007] An experimental method for studying the mechanism of uric acid-induced meniscus lesions comprises the following steps:

[0008] S1: Fasting venous blood test information of 1051 patients with meniscus injury and 2027 healthy subjects was collected, and serum renal function indicators of patients with meniscus injury and healthy subjects were compared;

[0009] S2.1: Isolate and extract MeSCs from the meniscus tissue of patients undergoing orthopedic knee surgery, and then use flow cytometry to detect the effect of UA on MeSCs cycle changes and apoptosis, detect their differentiation and verify the effect of UA on the differentiation potential of MeSCs, and produce differentiated cells for staining; and use a variety of stains to stain the differentiated cells to detect the effect of uric acid on the adipogenic, chondrogenic and osteogenic differentiation abilities of MeSCs;

[0010] S2.2: MeSCs were seeded in a well plate and different concentrations of UA were added. Then, the effect of UA on the proliferation ability of MeSCs was detected by adding CCK-8 reagent.

[0011] S2.3: qRT-PCR was used to detect the expression of inflammatory factors and matrix metalloproteinases and aggrecanases (ADAMTSs) genes; the expression of differentiation marker genes was verified by qRT-PCR experiments, and the effect of UA on the target genes of pro-inflammatory factors and matrix metalloproteinases in MeSCs was detected by real-time quantitative polymerase chain reaction;

[0012] S3: SA-β-Gal staining was performed on MeSCs treated with different concentrations of UA to observe the color changes of cells and verify the effect of UA on MeSCs aging; the changes in the expression of aging marker proteins p16 and p21 were detected by Western blot experiments;

[0013] S4: A hyperuricemia animal model of SD rats was established. The model rats were given uric acid by gavage. Then the meniscus tissue was extracted and the changes of the internal structure and collagen expression of the meniscus were observed by HE staining and safranin fast green staining.

[0014] S5: Transcriptome sequencing was performed on human MeSCs treated with different concentrations of uric acid to verify the molecular mechanism by which uric acid affects MeSCs, and protein expression of key signaling pathways was verified by Western blot experiments.

[0015] Preferably: in the step S2.1, when producing differentiated cells, the cells are first inoculated in a 6-well plate, with 6×104 cells in each well, and placed in a cell culture incubator; after 24-48 hours, the culture medium is replaced with chondrogenic induction medium, adipogenic induction medium and osteogenic induction medium; uric acid (at concentrations of 0.2 mM and 0.8 mM) is added to the differentiation medium in the experimental group, and the corresponding differentiation medium is added to the control group; the culture medium is replaced every three days and cultured for 21 days to produce differentiated cells.

[0016] Further: the dye uses Oil Red O staining reagent to detect differentiated adipocytes, Safranin O staining reagent to detect differentiated chondrocytes, and Alizarin Red S staining solution to detect differentiated osteocytes.

[0017] Furthermore: the concentrations of UA added in step S2.2 are 0, 0.1, 0.2, 0.4, and 0.8 mM, respectively.

[0018] As a preferred solution of the present invention: the CCK-8 reagent is added at 24, 48, or 72 hours after UA treatment, and the cells are incubated in a cell culture incubator in the dark for 2 hours, and then the absorbance at 450 nm is measured using a microplate reader.

[0019] As a further solution of the present invention: the concentration of UA added in step S3 is 0, 0.1, 0.2, 0.4, 0.8 mM, wherein 0 is the control group.

[0020] As a further solution of the present invention: the MeSCs are treated with UA for 48 hours before SA-β-Gal staining.

[0021] On the basis of the above scheme: in step S4, the model rats are gavaged with uric acid for six weeks.

[0022] On the basis of the above scheme: in step S2.2S, flow cytometry analysis with Annexin-V-APC / PI double staining was further performed to detect the effect of UA content on the maintenance of MeSCs cell number.

[0023] The beneficial effects of the present invention are:

[0024] 1. An experimental method to study the mechanism of uric acid-induced meniscus lesions. Multiple tests have proved that uric acid affects the stemness of MeSCs from multiple biological functional levels through a variety of complex molecular mechanisms, reduces the number of these stem cells that play an important role in maintaining meniscus function and repairing injuries, promotes degenerative lesions of meniscus tissue, and ultimately makes the meniscus more susceptible to tissue damage. There is a close correlation between uric acid and meniscus. High serum uric acid levels may be one of the potential causes of meniscus degenerative changes, providing valuable clues and important information for the early prevention of meniscus injuries and their clinical treatment.

[0025] 2. An experimental method to study the mechanism of uric acid-induced meniscus lesions. By comparing patients with meniscus injury and healthy subjects, the serum uric acid, blood urea nitrogen and creatinine values ​​of patients with meniscus injury were significantly higher than those of healthy subjects, with statistically significant differences, indicating that there is a certain clinical correlation between high uric acid and meniscus.

[0026] 3. An experimental method to study the mechanism of uric acid-induced meniscus lesions. Through cell differentiation staining experiments, it is proved that uric acid has different effects on different differentiation directions of MeSCs. It promotes the non-directional differentiation of MeSCs into osteoblasts and adipocytes, but inhibits the directional differentiation of MeSCs into chondrogenesis.

[0027] 4. An experimental method to study the mechanism of uric acid-induced meniscus lesions. SA-β-Gal staining and Western blot experiments proved that uric acid induces MeSCs senescence in a dose-dependent manner.

[0028] 5. An experimental method to study the mechanism of uric acid-induced meniscus lesions, which proves through a rat hyperuricemia animal model that uric acid significantly affects the tissue morphology of the meniscus of SD rats and obviously triggers pathological damage to the meniscus. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 It is a schematic diagram of the clinical correlation between high uric acid and the occurrence of meniscus injury in an experimental method for studying the mechanism of uric acid-induced meniscus lesions proposed by the present invention;

[0030] Figure 2 It is a schematic diagram of the effect of uric acid on the proliferation and death of MeSCs in an experimental method for studying the mechanism of uric acid-induced meniscus lesions proposed by the present invention;

[0031] Figure 3 It is a schematic diagram of the effect of uric acid on the differentiation ability of MeSCs in an experimental method for studying the mechanism of uric acid-induced meniscus lesions proposed by the present invention;

[0032] Figure 4 It is a schematic diagram of the effect of uric acid on the aging of MeSCs in an experimental method for studying the mechanism of uric acid-induced meniscus lesions proposed by the present invention;

[0033] Figure 5 This is a schematic diagram of the effect of uric acid on the expression of pro-inflammatory factors and matrix metalloproteinase genes of MeSCs in an experimental method for studying the mechanism of uric acid-induced meniscus lesions proposed by the present invention. DETAILED DESCRIPTION

[0034] The technical solution of this patent is further described in detail below in conjunction with specific implementation methods.

[0035] The embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and cannot be understood as limiting the present invention.

[0036] Embodiment 1:

[0037] An experimental method for studying the mechanism of uric acid-induced meniscus lesions, such as Figure 1-5 As shown, the following steps are included:

[0038] S1: Fasting venous blood test information of 1051 patients with meniscus tear (MT) and 2027 healthy subjects was collected, serum renal function indexes of patients with meniscus tear and healthy subjects were compared, and their statistical differences were calculated;

[0039] S2.1: MeSCs were isolated and extracted from the meniscus tissue of patients undergoing orthopedic knee surgery, and then flow cytometry was used to detect the effect of UA on the cycle changes and apoptosis of MeSCs. The cells were then inoculated in a 6-well plate with 6×104 cells per well and placed in a cell culture incubator; after 24-48 hours (cell density was approximately 30%), the culture medium was replaced with chondrogenic induction medium, adipogenic induction medium, and osteogenic induction medium; uric acid (at a concentration of 0.2 mM and 0.8 mM) was added to the differentiation medium in the experimental group, and the corresponding differentiation medium was added to the control group; the culture medium was replaced every three days for 21 days, and the differentiation was detected to verify the effect of UA on the differentiation potential of MeSCs, and differentiated cells for staining were produced;

[0040] Oil Red O staining reagent was used to detect differentiated adipocytes, and lipid droplets were observed to be red, while cell nuclei were observed to be blue. Safranin O staining reagent was used to detect differentiated chondrocytes, and dark red chondrocytes were observed under a microscope and photographed. Alizarin Red S staining solution was used to evenly cover the cell surface, and stained osteocytes containing mineral deposits were observed under a microscope to detect the effects of uric acid on their adipogenic, chondrogenic, and osteogenic differentiation abilities.

[0041] S2.2: MeSCs were seeded in a 96-well plate, with 1500 cells in each well, and three replicates were set up; on the second day, UA of various concentrations (0, 0.1, 0.2, 0.4, 0.8 mM) was added to the plate; CCK-8 reagent (the ratio of DMEM / F12 to CCK8 was 10:1) was added at 24, 48, and 72 hours after UA treatment. After incubation in a cell culture incubator for 2 hours in the dark, the absorbance at 450 nm was measured using a microplate reader to detect the effect of UA on the proliferation ability of MeSCs;

[0042] S2.3: Use qRT-PCR to detect the expression of inflammatory factors and genes such as matrix metalloproteinases (MMPs) and aggrecanases (ADAMTSs); verify the expression of differentiation marker genes through qRT-PCR experiments, and detect the effect of UA on target genes such as MeSCs pro-inflammatory factors and matrix metalloproteinases by real-time quantitative polymerase chain reaction.

[0043] S3: MeSCs treated with different concentrations of UA (0, 0.1, 0.2, 0.4, 0.8 mM, 0 for the control group) were stained with SA-β-Gal for 48 hours to observe the color change of cells and verify the effect of uric acid on MeSCs aging; the expression changes of aging marker proteins p16 and p21 were detected by Western blot experiment;

[0044] S4: A hyperuricemia animal model of SD rats was established. Uric acid was administered orally to the model rats for six weeks. Then the meniscus tissue was extracted and the changes in the internal structure and collagen expression of the meniscus were observed using HE staining and safranin fast green staining.

[0045] S5: Transcriptome sequencing was performed on human MeSCs treated with different concentrations of uric acid to verify the molecular mechanism by which uric acid affects MeSCs, and protein expression of key signaling pathways was verified by Western blot experiments.

[0046] like Figure 1 As shown in the figure, the serum uric acid, blood urea nitrogen and creatinine values ​​of patients with meniscus injury in step S1 are significantly higher than those of healthy subjects, and there is a statistical difference, indicating that there is a certain clinical correlation between high uric acid and meniscus. Figure 1 The serum uric acid, blood urea nitrogen, creatinine and blood glucose levels of healthy subjects in patients with meniscus injury are compared from left to right.

[0047] like Figure 3 As shown, in step S2.1, crystal violet staining was used to find that the separated meniscus cells had good clonality and the self-renewal ability of MeSCs. Flow cytometry detected that the mesenchymal stem cells of the cultured cells met the characteristics of mesenchymal stem cells and could be used as meniscus mesenchymal stem cells (MeSCs) for subsequent experiments.

[0048] Alizarin red staining revealed only a small amount of calcium salt deposition; after adipogenic induction, oil red O staining revealed obvious lipid droplets; after chondrogenic induction, safranin O staining revealed that the cells were brown-red and aggregated together, indicating that meniscus cells had the multidirectional differentiation ability of MeSCs;

[0049] Uric acid has different effects on different differentiation directions of MeSCs, promoting the non-directional differentiation of MeSCs into osteoblasts and adipocytes ( Figure 3 a, b, c, d), while inhibiting the directional differentiation of MeSCs into cartilage ( Figure 3 e, f).

[0050] like Figure 2As shown in the S2.2 step test, high concentration of UA significantly inhibited the proliferation ability of MeSCs ( Figure 2 a), and then further analyzed by flow cytometry using Annexin-V-APC / PI double staining ( Figure 2 b) The results show that the UA content in the environment is not conducive to the maintenance of MeSCs cell number.

[0051] like Figure 5 As shown in the S2.3 step test, TNF-α, IL-1β and IL-6 genes showed significant concentration-dependent upregulation with UA treatment ( Figure 5 a). The gene expression levels of multiple members of the two major families of extracellular matrix metalloproteinases in the meniscus, MMPs and ADAMTSs, including MMP2, MMP3, MMP13, and ADAMTS1, ADAMTS4, and ADAMTS5, increased with the increase of uric acid concentration ( Figure 5 b) These results suggest that high uric acid may interfere with the extracellular matrix regulation ability of MeSCs, promote the formation of microenvironmental inflammatory phenotypes and degradation of extracellular matrix.

[0052] like Figure 4 As shown, the experimental results in step S3 show that as the concentration of uric acid gradually increases, the proportion of cells stained blue-green gradually increases in the SA-β-Gal staining and Western blot experimental results ( Figure 4 a, b), indicating that high concentrations of uric acid can promote MeSCs senescence in a concentration-dependent manner. In addition, the senescence factors p16 and p21 were detected by protein immunoblotting, and it was found that as the concentration of uric acid gradually increased, the expression of the two proteins gradually increased, and the change was most significant when the concentration was 0.8mM ( Figure 4 c, d), indicating that uric acid induces MeSCs senescence in a dose-dependent manner.

[0053] HE staining in the S4 step showed that the meniscus cells of the control group were arranged in an elliptical shape and in a parallel and uniform manner, and the collagen was arranged smoothly and orderly. In the meniscus tissue of hyperuricemia rats, the number of meniscus cells was significantly reduced, the tissue was thinned, and the vascular density and distribution were significantly atrophied. Safranin fast green staining showed that compared with the control group, the red-stained cartilage tissue in the hyperuricemia group was significantly reduced, and the terminal extension was poor. It shows that hyperuricemia can promote tissue loss and degenerative lesions in meniscus cartilage, which has triggered pathological damage to the meniscus.

[0054] The test results in step S5 showed that when the uric acid concentration was 0.2 mM, which is a near-physiological concentration, there was no significant change in gene expression compared with the control group. When the uric acid concentration increased to a non-physiological concentration of 0.8 mM, the genes of MeSCs from different individuals could still show relatively consistent significant changes relative to the control group. The expression of 7 genes was significantly upregulated, and the expression of 15 genes was significantly downregulated. Analysis of differentially expressed genes showed that high uric acid affects a series of biological signals of MeSCs. These pathways are mainly involved in biological processes such as metal ion binding and extracellular matrix regulation. Representative signals include the PI3K-AKT pathway, FAK signal, etc.

[0055] Transcriptome sequencing analysis results showed that uric acid treatment significantly affected the intracellular signals of MeSCs represented by PI3K-AKT, FAK and ECM-receptor. Western blot results showed that uric acid upregulated the levels of proteins related to the AKT-mTOR signaling pathway in MeSCs and inhibited the autophagy level of MeSCs. Uric acid inhibited the FAK signaling pathway and promoted the expression of ferroptosis marker proteins.

[0056] In this embodiment, the above results indicate that the high concentration of uric acid in patients with hyperuricemia may affect the cellular stemness of MeSCs from multiple biological functional levels through a variety of complex molecular mechanisms, reduce the number of these stem cells that play an important role in maintaining meniscus function and repairing damage, promote degenerative lesions of meniscus tissue, and ultimately make the meniscus more susceptible to tissue damage. There is a close correlation between uric acid and meniscus, and high serum uric acid levels may be one of the potential causes of degenerative changes in the meniscus, providing valuable clues and important information for the early prevention of meniscus injury and its clinical treatment.

[0057] The above is a preferred specific implementation manner of the present invention, and the protection scope of the present invention is not limited thereto. Any modification, equivalent substitution and improvement made by any technician familiar with the field within the technical scope disclosed by the present invention in combination with the prior art or public common sense, within the spirit and principle of the present invention, shall be covered by the protection scope of the present invention.

Claims

1. An experimental method for studying the mechanism of uric acid-induced meniscus lesions, characterized in that: The steps include: S1: Fasting venous blood test information of 1051 patients with meniscus injury and 2027 healthy subjects was collected, and serum renal function indicators of patients with meniscus injury and healthy subjects were compared; S2.1: Isolate and extract MeSCs from the meniscus tissue of patients undergoing orthopedic knee surgery, and then use flow cytometry to detect the effect of UA on MeSCs cycle changes and apoptosis, detect their differentiation and verify the effect of UA on the differentiation potential of MeSCs, and produce differentiated cells for staining; and use a variety of stains to stain the differentiated cells to detect the effect of uric acid on the adipogenic, chondrogenic and osteogenic differentiation abilities of MeSCs; S2.2: MeSCs were seeded in a well plate and different concentrations of UA were added. Then, the effect of UA on the proliferation ability of MeSCs was detected by adding CCK-8 reagent. S2.3: qRT-PCR was used to detect the expression of inflammatory factors and matrix metalloproteinases and aggrecanases (ADAMTSs) genes; the expression of differentiation marker genes was verified by qRT-PCR experiments, and the effect of UA on the target genes of pro-inflammatory factors and matrix metalloproteinases in MeSCs was detected by real-time quantitative polymerase chain reaction; S3: SA-β-Gal staining was performed on MeSCs treated with different concentrations of UA to observe the color changes of cells and verify the effect of UA on MeSCs aging; the changes in the expression of aging marker proteins p16 and p21 were detected by Western blot experiments; S4: A hyperuricemia animal model of SD rats was established. The model rats were given uric acid by gavage. Then the meniscus tissue was extracted and the changes of the internal structure and collagen expression of the meniscus were observed by HE staining and safranin fast green staining. S5: Transcriptome sequencing was performed on human MeSCs treated with different concentrations of uric acid to verify the molecular mechanism by which uric acid affects MeSCs, and protein expression of key signaling pathways was verified by Western blot experiments.

2. The experimental method for studying the mechanism of uric acid-induced meniscus lesions according to claim 1, characterized in that: In the step S2.1, when producing differentiated cells, the cells are first inoculated in a 6-well plate, with 6×104 cells in each well, and placed in a cell culture incubator; after 24-48 hours, the culture medium is replaced with chondrogenic induction medium, adipogenic induction medium and osteogenic induction medium; uric acid (at a concentration of 0.2 mM and 0.8 mM) is added to the differentiation medium in the experimental group, and the corresponding differentiation medium is added to the control group; the culture medium is replaced every three days and cultured for 21 days to produce differentiated cells.

3. The experimental method for studying the mechanism of uric acid-induced meniscus lesions according to claim 2, characterized in that: The dye uses Oil Red O staining reagent to detect differentiated adipocytes, Safranin O staining reagent to detect differentiated chondrocytes, and Alizarin Red S staining solution to detect differentiated osteocytes.

4. The experimental method for studying the mechanism of uric acid-induced meniscus lesions according to claim 1, characterized in that: The concentrations of UA added in step S2.2 were 0, 0.1, 0.2, 0.4, and 0.8 mM, respectively.

5. The experimental method for studying the mechanism of uric acid-induced meniscus lesions according to claim 4, characterized in that: The CCK-8 reagent was added at 24, 48, and 72 hours after UA treatment, and the cells were incubated in a cell culture incubator in the dark for 2 hours, and then the absorbance at 450 nm was measured using a microplate reader.

6. The experimental method for studying the mechanism of uric acid-induced meniscus lesions according to claim 1, characterized in that: The concentrations of UA added in step S3 were 0, 0.1, 0.2, 0.4, and 0.8 mM, where 0 was the control group.

7. The experimental method for studying the mechanism of uric acid-induced meniscus pathology according to claim 6, characterized in that: The MeSCs were treated with UA for 48 hours before SA-β-Gal staining.

8. The experimental method for studying the mechanism of uric acid-induced meniscus lesions according to claim 1, characterized in that: In step S4, the model rats were gavaged with uric acid for six weeks.

9. The experimental method for studying the mechanism of uric acid-induced meniscus lesions according to claim 4, characterized in that: In step S2.2S, flow cytometry analysis with Annexin-V-APC / PI double staining was further performed to detect the effect of UA content on the maintenance of MeSCs cell number.